Overview

Cerebras Systems accelerates artificial intelligence (AI) processes with its CS-2 system, which replaces traditional clusters of graphics processing units (GPUs) and simplifies AI operations by eliminating complex programming and management. The CS-2 system provides faster results for clients in various industries, including pharmaceuticals and government research labs, enabling quicker AI training and lower latency in AI inference. Cerebras generates revenue through the sale of its hardware and software solutions, distinguishing itself with the largest processor in the industry. The company's goal is to simplify and accelerate AI tasks, reducing costs associated with AI research and development.

Simplify's Take

What believers are saying

• Growing AI model efficiency demand aligns with Cerebras' energy-efficient accelerators.
• AI democratization increases need for user-friendly systems like Cerebras' CS-2.
• Pharmaceutical industry's push for faster drug discovery boosts demand for Cerebras' technology.

What critics are saying

• Competition from NVIDIA and Graphcore could impact Cerebras' market share.
• Rapid AI model evolution may necessitate frequent hardware updates, increasing R&D costs.
• Supply chain vulnerabilities could delay production of Cerebras' hardware.

What makes Cerebras unique

• Cerebras' Wafer-Scale Engine is the largest chip ever built for AI.
• The CS-2 system replaces traditional GPU clusters, simplifying AI computations.
• Cerebras serves diverse industries, including pharmaceuticals and government research labs.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$700.4M

Above

Industry Average

Funded Over

6 Rounds

Notable Investors:

Coatue ManagementBenchmarkSequoia CapitalSV Angel

Notable Investors:

Coatue ManagementBenchmarkSequoia CapitalSV Angel

$250,000,000

Series F

Nov 2021

Series F funding comparison data is currently unavailable. We're working to provide this information soon!

Series F Funding Comparison

Coming Soon

View all funding stages